VTL — Invictus Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$3.60m
- AU$3.83m
- AU$0.00m
Annual cashflow statement for Invictus Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2015 June 30th | 2016 June 30th | 2017 June 30th | 2018 June 30th | 2019 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.18 | 0.926 | 0.83 | 0 | 0 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -18.2 | -14.3 | -4.02 | 0 | -0.584 |
| Capital Expenditures | -0.343 | -0.008 | 0 | 0 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.432 | -1.1 | 0 | 0 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.775 | -1.1 | 0 | 0 | — |
| Financing Cash Flow Items | -0.641 | -1.06 | 0 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.2 | 10.7 | 1.48 | 0 | 0.585 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.66 | -4.67 | -2.55 | 0 | 0.001 |